← Leaderboards
Christopher R Defilippi
University Of Virginia
$816,270
Attributed
$1,632,539
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $736.4K · FY2021–23$1M$750K$500K$250K$0
'21
'22
'23
Funding mix
By agency
NIH$1,632,539 · 2
By mechanism
R01$1,175,680 · 1
R21$456,859 · 1
Top collaborators
- Lauren Beth Cooper3 shared
- Kenneth Walsh2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Jaideep Kapur$24,874,862
- Harald W Sontheimer$24,930,190
- Golam Mohi$10,072,497
- Benjamin D Kozower$3,843,714
- William A Petri$62,342,757
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingAcutePersonsProspectiveGenderCardiacHospitalizationMortalityEnrollmentRaceHospitalsBloodBlood-Based BiomarkerFoundationsAffectFollow-UpFunctional DisorderBiologicalAncillary StudyCessation Of LifeEfracClinical EfficacyBiological MarkersEnzyme-Linked Immunosorbent Assay
Grant awards (5)
The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization$387,840
R01 · FY2023 · HL
The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization$388,080
R01 · FY2022 · HL
Clonal hematopoiesis and severity of COVID-19 disease$120,235
R21 · FY2022 · AG
The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization$399,760
R01 · FY2021 · HL
Clonal hematopoiesis and severity of COVID-19 disease$336,624
R21 · FY2021 · AG